Eli Lilly and Company (LLY) Stock Forecast & Price Target
Eli Lilly and Company · NYSE
$1122.29-27.07 (-2.36%)
15-min delayed · Sep 8, 3:45 PM ET · Get real-time quotes →
The Quantellect read.Of the 21 firms covering Eli Lilly and Company, 18 rate it Buy or better, 2 sit at Hold, and 1 rate it Sell or worse, a strong buy consensus. Targets span $850.00 to $1600.00, a moderate spread. The average target of $1314.32 sits 17% above the current $1122.29. The rating mix has held broadly steady over recent months. On the fundamentals, the Street sees consensus EPS building from about $9.98 next quarter toward $47.26 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS21 ratings
Strong Buy
Strong Buy00%
Buy1886%
Hold210%
Sell15%
Strong Sell00%
Based on 21 analysts giving stock ratings to Eli Lilly and Company.
As of Sep, 18 of 20 firms rate LLY a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
LLY EPS & revenue forecast
EPS · NEXT QUARTER
$9.98
Range $9.15 – $11.64 · 17 analysts · +32% YoY
Next period, 17 analysts expect Eli Lilly and Company to earn $9.98 a share (range $9.15 – $11.64), versus $7.54 a year earlier. Full-year consensus is $36.71, growing to $47.26 the year after.
REVENUE · NEXT QUARTER
$23.2B
Range $22.1B – $24.8B · 17 analysts · +20% YoY
Revenue is expected to reach $23.2B (range $22.1B – $24.8B), +20.3% year-over-year. Full-year consensus is $88.2B, rising to $101.8B next year.
Top analysts covering Eli Lilly and Company
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on LLY.
#1
Jason Gerberry
B of A Securities · Rank #125
Buy
$1344.00+19.8% to target
Overall win rate
46%
+ Follow
#2
Terence Flynn
Morgan Stanley
Buy
$1419.00+26.4% to target
Coverage
—
+ Follow
#3
CS
Chris Schott
JP Morgan
Buy
$1400.00+24.7% to target
Coverage
—
+ Follow
#4
Carter Gould
Cantor Fitzgerald
Buy
$1410.00+25.6% to target
Coverage
—
+ Follow
#5
Mohit Bansal
Wells Fargo
Buy
$1330.00+18.5% to target
Coverage
—
+ Follow
LLY stock forecast FAQ
What is LLY's average 12-month price target?+
The 19 analysts with a live target average $1314.32 for Eli Lilly and Company over the next 12 months, ranging from a $1600.00 high to a $850.00 low.
Is LLY stock a Buy, Sell or Hold right now?+
The current consensus is Strong Buy. Of the 21 analyst ratings, 18 are Buy or Strong Buy, 2 are Hold, and 1 are Sell or Strong Sell.
What are the highest and lowest price targets for LLY?+
The Street-high target is $1600.00 (Citigroup), and the Street-low is $850.00 (HSBC). The average of all 19 active targets is $1314.32.
How many Wall Street analysts cover LLY?+
21 analysts have an active rating on Eli Lilly and Company, and 19 firms carry a live 12-month price target.
Who is the most accurate analyst covering LLY?+
Among analysts who currently cover LLY, Jason Gerberry of B of A Securities has the strongest overall Quantellect track record (Rank #125). Their current call is Buy with a $1344.00 target.
What is Eli Lilly and Company's projected EPS for next quarter?+
The consensus estimate is $9.98 per share (range $9.15 – $11.64) across 17 analysts. Full-year EPS is projected at $36.71, rising to $47.26 the following year.
How much revenue is Eli Lilly and Company expected to report next quarter?+
Consensus revenue is $23.2B (range $22.1B – $24.8B). Full-year revenue is projected at $88.2B, growing to $101.8B next year.
Have analysts been upgrading or downgrading LLY lately?+
As of Sep, 18 of 20 firms rate LLY a Buy (1 Hold, 1 Sell), the standing distribution of every covering firm's most recent active call.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their LLY calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.
